These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 29257214)
1. Icariin ameliorates dexamethasone‑induced bone deterioration in an experimental mouse model via activation of microRNA‑186 inhibition of cathepsin K. Ma Y; Yang H; Huang J Mol Med Rep; 2018 Jan; 17(1):1633-1641. PubMed ID: 29257214 [TBL] [Abstract][Full Text] [Related]
2. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838 [TBL] [Abstract][Full Text] [Related]
3. Icariin possesses chondroprotective efficacy in a rat model of dexamethasone-induced cartilage injury through the activation of miR-206 targeting of cathepsin K. Liu N; Zhang T; Cao BR; Luan FY; Liu RX; Yin HR; Wang WB Int J Mol Med; 2018 Feb; 41(2):1039-1047. PubMed ID: 29207029 [TBL] [Abstract][Full Text] [Related]
4. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats. Yang Y; Nian H; Tang X; Wang X; Liu R J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481 [TBL] [Abstract][Full Text] [Related]
5. Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice. Zhang J; Song J; Shao J Int J Clin Exp Med; 2015; 8(5):7306-14. PubMed ID: 26221270 [TBL] [Abstract][Full Text] [Related]
6. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. Sun P; Liu Y; Deng X; Yu C; Dai N; Yuan X; Chen L; Yu S; Si W; Wang X; Wu D; Liu S; Pang H Phytomedicine; 2013 Aug; 20(11):975-9. PubMed ID: 23746958 [TBL] [Abstract][Full Text] [Related]
7. Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo. Feng R; Feng L; Yuan Z; Wang D; Wang F; Tan B; Han S; Li T; Li D; Han Y Cell Biochem Biophys; 2013 Sep; 67(1):189-97. PubMed ID: 23417569 [TBL] [Abstract][Full Text] [Related]
8. Aqueous extract of pomegranate seed attenuates glucocorticoid-induced bone loss and hypercalciuria in mice: A comparative study with alendronate. Zhang Y; Shao J; Wang Z; Yang T; Liu S; Liu Y; Fan X; Ye W Int J Mol Med; 2016 Aug; 38(2):491-8. PubMed ID: 27278225 [TBL] [Abstract][Full Text] [Related]
9. Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice. Cheng Y; Wang WL; Liang JJ Int J Clin Exp Pathol; 2015; 8(1):394-403. PubMed ID: 25755727 [TBL] [Abstract][Full Text] [Related]
10. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. Ren H; Shen G; Tang J; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Liang D; Yao Z; Yang Z; Jiang X Sci Rep; 2017 Sep; 7(1):10617. PubMed ID: 28878388 [TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim. Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Yongtao Z; Kunzheng W; Jingjing Z; Hu S; Jianqiang K; Ruiyu L; Chunsheng W Endocrine; 2014 Nov; 47(2):598-608. PubMed ID: 24519760 [TBL] [Abstract][Full Text] [Related]
13. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate. Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129 [TBL] [Abstract][Full Text] [Related]
14. JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice. Guo Y; Wang L; Ma R; Mu Q; Yu N; Zhang Y; Tang Y; Li Y; Jiang G; Zhao D; Mo F; Gao S; Yang M; Kan F; Ma Q; Fu M; Zhang D Life Sci; 2016 Mar; 148():24-30. PubMed ID: 26892148 [TBL] [Abstract][Full Text] [Related]
15. Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis. Stone JA; McCrea JB; Witter R; Zajic S; Stoch SA Br J Clin Pharmacol; 2019 Jun; 85(6):1072-1083. PubMed ID: 30663085 [TBL] [Abstract][Full Text] [Related]
16. Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis. Yin M; Zhou D; Jia F; Su X; Li X; Sun R; Li J J Orthop Surg Res; 2023 Jun; 18(1):409. PubMed ID: 37277810 [TBL] [Abstract][Full Text] [Related]
17. [Reducing bone resorption by cathepsin K inhibitor and treatment of osteoporosis]. Watanabe R; Okazaki R Clin Calcium; 2014 Jan; 24(1):59-67. PubMed ID: 24369281 [TBL] [Abstract][Full Text] [Related]
18. Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis. Sun X; Wei J; Lyu J; Bian T; Liu Z; Huang J; Pi F; Li C; Zhong Z J Nanobiotechnology; 2019 Jan; 17(1):10. PubMed ID: 30670021 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. Mukherjee K; Chattopadhyay N Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079 [TBL] [Abstract][Full Text] [Related]
20. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Zhang Y; Li Q; Li X; Wan HY; Wong MS Br J Nutr; 2010 Oct; 104(7):965-71. PubMed ID: 20487580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]